Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

Featured Speakers: Caroline Le Poole, PhD, Professor of Dermatology and Microbiology-Immunology at Northwestern University Feinberg School of Medicine

What's Inside

In this Webinar we discuss:

Review published data showing how polyfunctional GD3 CAR T cells created to target the TSC tumor immunogens can substantially reduce tumor burden in a mouse model.

Learn how IsoPlexis' single-cell multiplex cytokine profiling uncovered rare polyfunctional CAR T cell subsets indicating the functional capacity for improved anti-tumor response.

Watch the Q&A session with our expert panelist.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Watch the Webinar